Insulin-like growth factor-1 gene polymorphism in rheumatoid arthritis patients

Scandinavian Journal of Rheumatology

Volumn 41, Issue 6, 2012, Pages 421-425

  Dhaunsi, G S ^a   Uppal, S S ^a   Haider, M Z ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GENOMIC DNA; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOMEDIN C;

ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MODEL; DISEASE SEVERITY; DNA POLYMORPHISM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; ALLELES; ARTHRITIS, RHEUMATOID; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84869454981     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.691177     Document Type: Article

References (25)

1. Choi SI, Brahn E. Rheumatoid arthritis therapy: Advances from bench to bedside. Autoimmunity 2010;43:478-92.
2. Boonen A, Severens JL. The burden of illness of rheumatoid arthritis. Clin Rheumatol 2011;30:S3-8.
3. Paleolog EM. The vasculature in rheumatoid arthritis: cause or consequence? Int J Exp Pathol 2009;90:249-61.
4. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006;83:735-43. (Pubitemid 44713134)
5. Granado M, Martin AI, Villanua MA, Lopez-Calderon A. Experimental arthritis inhibits the insulin-like growth factor-1 axis and induces muscle wasting through cyclooxygenase-2 activation. Am J Physiol Endocrinol Metabol 2007;292:E1656-65. (Pubitemid 47084701)
6. Soto L, Martin AI, Vara E, Lopez-Calderon A. Cyclosporin a treatment is able to revert the decrease in circulating GH and IGF-1 and the increase in IGFBPs induced by adjuvant arthritis. Horm Metab Res 2001;33:590-5. (Pubitemid 33015961)
7. Clemmons DR. Role of IGF-1 in skeletal muscle mass maintenance. Trends Endocrinol Metab 2009;20:349-56.
8. Edwall D, Schalling M, Jennische E, Norstedt G. Induction of insulin-like growth factor 1 messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 1989;124:820-5. (Pubitemid 19057074)
9. Niu T, Rosen CJ. The insulin-like growth factor-1 gene and osteoporosis: A critical appraisal. Gene 2005;361:38-56. (Pubitemid 41506932)
10. Tan K, Baxter RC. Serum insulin-like growth factor 1 levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 1986;63:651-5. (Pubitemid 16050565)
11. Donath MY, Jenni R, Brunner HP, Anrig M, Kohli S, Glatz Y, et al. Cardiovascular and metabolic effects of insulin-like growth factor 1 at rest and during exercise in humans. J Clin Endocrinol Metab 1996;81:4089-94. (Pubitemid 26380422)
12. Orozco G, Rueda B, Martin J. Genetic basis of rheumatoid arthritis. Biomed Pharmacother 2006;60:656-62.
13. Kochi Y, Suzuki A, Yamada R, Yamamoto K. Genetic of rheumatoid arthritis: Underlying evidence of ethnic differences. J Autoimmun 2009;32:158-62.
14. Uppal SS, Haider MZ, Hayat SJ, Abraham M, Sukumaran, J Dhaunsi GS. Significant association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with rheumatoid arthritis. J Rheumatol 2007;34:2395-9. (Pubitemid 350230661)
15. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the gene for IGF-1: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-42. (Pubitemid 32195230)
16. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using polymerase chain reaction. Am J Hum Genet 1989;44:388-96. (Pubitemid 19071233)
17. Rotwein P, Pollock KM, Didier DK, Krivi GG. Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 1986;261:4828-32. (Pubitemid 17204268)
18. Scott Dl, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094-108.
19. Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 2009;4:417-34.
20. Lequerre T, Coulouarn C, Derambure C, Lefebvre T, Vittecoq O, Daveau M, et al. A new tool for rheumatology: large-scale analysis of gene expression. Joint Bone Spine 2003;70:248-56. (Pubitemid 37064579)
21. Malemud CJ. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin Chim Acta 2007;375:10-19. (Pubitemid 44584237)
22. Denko CW, Malemud CJ. Role of growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheum 2005;35:24-34.
23. Grazul-Bilska AT, Johnson ML, Bilski JJ, Redmer DA, Reynolds LP, Abdullah A, et al. Wound healing: the role of growth factors. Drugs Today 2003;39:787-800. (Pubitemid 37500405)
24. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW, et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci USA 2010;107:3287-92.
25. Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical activity, and low bioavailable insulin-like growth factor. Scand J Rheumatol 2008;37:321-8.